These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30998378)

  • 1. Influence of Melanin Characteristics on Drug Binding Properties.
    Jakubiak P; Lack F; Thun J; Urtti A; Alvarez-Sánchez R
    Mol Pharm; 2019 Jun; 16(6):2549-2556. PubMed ID: 30998378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of memantine to melanin: influence of type of melanin and characteristics.
    Koeberle MJ; Hughes PM; Skellern GG; Wilson CG
    Pharm Res; 2003 Oct; 20(10):1702-9. PubMed ID: 14620529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an In Vitro-In Vivo Correlation for Melanin Binding and the Extension of the Ocular Half-Life of Small-Molecule Drugs.
    Jakubiak P; Cantrill C; Urtti A; Alvarez-Sánchez R
    Mol Pharm; 2019 Dec; 16(12):4890-4901. PubMed ID: 31670965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox activity of melanin from the ink sac of Sepia officinalis by means of colorimetric oxidative assay.
    Srisuk P; Correlo VM; Leonor IB; Palladino P; Reis RL
    Nat Prod Res; 2016; 30(8):982-6. PubMed ID: 26299816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Sepia melanin as a PD model to describe the binding characteristics of neuromelanin - A critical review.
    Schroeder RL; Double KL; Gerber JP
    J Chem Neuroanat; 2015; 64-65():20-32. PubMed ID: 25681296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin standard method: particle description.
    Zeise L; Murr BL; Chedekel MR
    Pigment Cell Res; 1992 Sep; 5(3):132-42. PubMed ID: 1409450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanin binding study of clinical drugs with cassette dosing and rapid equilibrium dialysis inserts.
    Pelkonen L; Tengvall-Unadike U; Ruponen M; Kidron H; Del Amo EM; Reinisalo M; Urtti A
    Eur J Pharm Sci; 2017 Nov; 109():162-168. PubMed ID: 28756205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoprotection of human retinal pigment epithelium cells against blue light-induced apoptosis by melanin free radicals from Sepia officinalis.
    Seagle BL; Gasyna EM; Mieler WF; Norris JR
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16644-8. PubMed ID: 17075067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium.
    Pitkänen L; Ranta VP; Moilanen H; Urtti A
    Pharm Res; 2007 Nov; 24(11):2063-70. PubMed ID: 17546409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of 3H-cocaine binding on melanin granules and human hair in vitro.
    Pötsch L; Skopp G; Rippin G
    Int J Legal Med; 1997; 110(2):55-62. PubMed ID: 9168320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery.
    Pescina S; Santi P; Ferrari G; Padula C; Cavallini P; Govoni P; Nicoli S
    Eur J Pharm Sci; 2012 Aug; 46(5):475-83. PubMed ID: 22484210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of melanin binding in ocular drug delivery.
    Rimpelä AK; Reinisalo M; Hellinen L; Grazhdankin E; Kidron H; Urtti A; Del Amo EM
    Adv Drug Deliv Rev; 2018 Feb; 126():23-43. PubMed ID: 29247767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Distribution to Retinal Pigment Epithelium: Studies on Melanin Binding, Cellular Kinetics, and Single Photon Emission Computed Tomography/Computed Tomography Imaging.
    Rimpelä AK; Schmitt M; Latonen S; Hagström M; Antopolsky M; Manzanares JA; Kidron H; Urtti A
    Mol Pharm; 2016 Sep; 13(9):2977-86. PubMed ID: 26741026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preparation procedures on the morphology of melanin from the ink sac of Sepia officinalis.
    Liu Y; Simon JD
    Pigment Cell Res; 2003 Feb; 16(1):72-80. PubMed ID: 12519128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Molecular Drivers of Melanin Binding To Support Rational Design of Small Molecule Ophthalmic Drugs.
    Jakubiak P; Reutlinger M; Mattei P; Schuler F; Urtti A; Alvarez-Sánchez R
    J Med Chem; 2018 Nov; 61(22):10106-10115. PubMed ID: 30398862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]flunitrazepam binding to melanin.
    Testorf MF; Kronstrand R; Svensson SP; Lundström I; Ahlner J
    Anal Biochem; 2001 Nov; 298(2):259-64. PubMed ID: 11700981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.
    Karlsson O; Berg C; Brittebo EB; Lindquist NG
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):120-30. PubMed ID: 19154235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical factors affecting chloroquine binding to melanin.
    Schroeder RL; Pendleton P; Gerber JP
    Colloids Surf B Biointerfaces; 2015 Oct; 134():8-16. PubMed ID: 26141438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
    Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
    Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular Tissue.
    Reilly J; Williams SL; Forster CJ; Kansara V; End P; Serrano-Wu MH
    J Pharm Sci; 2015 Dec; 104(12):3997-4001. PubMed ID: 26524700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.